Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 02/16/2007
Entire Document
 
 

TABLE OF CONTENTS
                     
                Page
ARTICLE I — CORPORATE OFFICES     1  
      1.1
1.2
   
REGISTERED OFFICE
OTHER OFFICES
    1
1
 
           
 
     
ARTICLE II — MEETINGS OF STOCKHOLDERS     1  
      2.1    
PLACE OF MEETINGS
    1  
      2.2    
ANNUAL MEETING
    1  
      2.3    
SPECIAL MEETING
    1  
      2.4    
ADVANCE NOTICE PROCEDURES; NOTICE OF STOCKHOLDERS’ MEETINGS
    2  
      2.5    
MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE
    3  
      2.6    
QUORUM
    3  
      2.7    
ADJOURNED MEETING; NOTICE
    4  
      2.8    
CONDUCT OF BUSINESS
    4  
      2.9    
VOTING
    4  
      2.10    
STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING
    4  
      2.11    
RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS
    4  
      2.12    
PROXIES
    5  
      2.13    
LIST OF STOCKHOLDERS ENTITLED TO VOTE
    5  
      2.14    
INSPECTORS OF ELECTION
    5  
           
 
     
ARTICLE III — DIRECTORS     6  
      3.1    
POWERS
    6  
      3.2    
NUMBER OF DIRECTORS
    6  
      3.3    
ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS
    6  
      3.4    
RESIGNATION AND VACANCIES
    7  
      3.5    
PLACE OF MEETINGS; MEETINGS BY TELEPHONE
    7  
      3.6    
REGULAR MEETINGS
    8  
      3.7    
SPECIAL MEETINGS; NOTICE
    8  
      3.8    
QUORUM
    8  
      3.9    
BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING
    8  
      3.10    
FEES AND COMPENSATION OF DIRECTORS
    9  
      3.11    
REMOVAL OF DIRECTORS
    9  
           
 
     
ARTICLE IV — COMMITTEES     9  
      4.1    
COMMITTEES OF DIRECTORS
    9  
      4.2    
COMMITTEE MINUTES
    9  
      4.3    
MEETINGS AND ACTION OF COMMITTEES
    9  
           
 
     
ARTICLE V — OFFICERS     10  
      5.1    
OFFICERS
    10  
      5.2    
APPOINTMENT OF OFFICERS
    10  
      5.3    
SUBORDINATE OFFICERS
    10  

-i-